Safety and efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab in clinical practice for patients with chemorefractory metastatic colorectal cancer: A retrospective comparative study.

Yoshinori Kagawa,Yohei Nose,Taishi Hata,Kenji Kawai,Takuya Sakamoto,Kohei Murakami,Yoshiteru Katsura,Yoshiaki Ohmura,Toru Masuzawa,Atsushi Takeno,Yutaka Takeda,Kohei Murata

Safety and efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab in clinical practice for patients with chemorefractory metastatic colorectal cancer: A retrospective comparative study.

2020

Yoshinori Kagawa
Yohei Nose
Taishi Hata
Kenji Kawai
Takuya Sakamoto
Kohei Murakami
Yoshiteru Katsura
Yoshiaki Ohmura
Toru Masuzawa
Atsushi Takeno
Yutaka Takeda
Kohei Murata

112Background: Trifluridine/tipiracil (FTD/TPI) significantly improves overall survival (OS) in patients with chemorefractory metastatic colorectal cancer (mCRC). The phase I/II C-TASKFORCE study o...

Keywords:

Internal medicine
Colorectal cancer
Bevacizumab
Medicine
Oncology
Clinical Practice
Pathology
in patient
Tipiracil
overall survival
Trifluridine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations